Literature DB >> 8594224

Mechanisms of secondary brain damage in global and focal ischemia: a speculative synthesis.

B K Siesjö1, K Katsura, Q Zhao, J Folbergrová, K Pahlmark, P Siesjö, M L Smith.   

Abstract

The objective of this article is to amalgamate previous results into a speculative synthesis that sheds light on the causes of secondary brain damage following either global/forebrain or focal ischemia. The hypothesis is based on the well-founded assumption that the pathophysiology of the brain damage incurred by global or forebrain ischemia is different from that of focal ischemia. In the former, the ischemia is usually dense and of brief duration and, provided that reperfusion is adequate, cell damage is conspicuously delayed, mostly affecting selectively vulnerable neurons. In contrast, focal ischemia is either long-lasting or permanent, and it is usually less severe, particularly in the perifocal penumbral regions. The lesion is typically pan-necrotic ("infarction"), initially affecting the focus supplied by the occluded artery, later invading the penumbra zone. Available results allow a restatement of the calcium hypothesis of cell death. In global or forebrain ischemia, calcium influx through channels gated by voltage or glutamate receptors is envisaged to trigger reactions that limit the survival of neurons during reperfusion, leading to secondary neuronal death after hours or days of survival. It can be hypothesized that the initial insult leads to a sustained alteration of membrane calcium handling, resulting in slow, gradual calcium overload of mitochondria. Alternatively, a sustained perturbation of the intracellular signal transduction pathway leads to changes in transcription or translation, bereaving the cells of heat shock and stress proteins, of trophic factors, or of enzymes required for survival. However, with the possible exception of the gerbil, neither microvascular failure nor primary mitochondrial dysfunction is believed to be involved. In focal ischemia, similar reactions are probably triggered by calcium influx, whether this is sustained (the focus) or intermittent (the penumbra). However, these play a minor role in cell death since they are overridden by reactions producing mediators of rapidly developing secondary damage, affecting either microvessels or mitochondria. Very probably, some of these mediators are free radicals, or nitric oxide, or other reactive metabolites, emanating from lipid hydrolysis and arachidonic acid metabolism. During continuous ischemia, or during recirculation following 1-3 h of ischemia, these mediators activate adhesion molecules in endothelial cells or polymorphonuclear leucocytes, or oxidize key proteins. The result is either failure of microcirculation ("capillary plugging"), or sustained mitochondrial failure. Since calcium influx is an initial event, agents reducing presynaptic depolarization and calcium entry through glutamate receptor-gated and other calcium channels have predictably a narrow therapeutic window; however, since spin trapping agents of the nitrone class act many hours after the induction of focal ischemia, their therapeutic window is potentially very wide. This may be because expression of mRNAs for adhesion molecules and their synthesis are relatively slow processes, and because the nitrones act on events that involve adhesion of leukocytes to the endothelial cells, with plugging of capillaries and postcapillary venules, and on the ensuing inflammatory response.

Entities:  

Mesh:

Year:  1995        PMID: 8594224     DOI: 10.1089/neu.1995.12.943

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  26 in total

1.  Vascular Dysfunction in Brain Hemorrhage: Translational Pathways to Developing New Treatments from Old Targets.

Authors:  Paul A Lapchak; Qiang Wu
Journal:  J Neurol Neurophysiol       Date:  2011

Review 2.  Vascular plasticity in cerebrovascular disorders.

Authors:  Lars I H Edvinsson; Gro Klitgaard Povlsen
Journal:  J Cereb Blood Flow Metab       Date:  2011-05-11       Impact factor: 6.200

3.  Irreversible aggregation of protein synthesis machinery after focal brain ischemia.

Authors:  F Zhang; C L Liu; B R Hu
Journal:  J Neurochem       Date:  2006-07       Impact factor: 5.372

4.  A tertiary care center's experience with therapeutic hypothermia after pediatric cardiac arrest.

Authors:  Ericka L Fink; Robert S B Clark; Patrick M Kochanek; Michael J Bell; R Scott Watson
Journal:  Pediatr Crit Care Med       Date:  2010-01       Impact factor: 3.624

5.  Nimodipine modulates Bcl-2 and Bax mRNA expression after cerebral ischemia.

Authors:  Changqin Liu; Ruixiang Zhou; Shenggang Sun
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2004

6.  Inhibition of mitochondrial function in astrocytes: implications for neuroprotection.

Authors:  Ludmila A Voloboueva; Sang Won Suh; Raymond A Swanson; Rona G Giffard
Journal:  J Neurochem       Date:  2007-08       Impact factor: 5.372

7.  Drug-like property profiling of novel neuroprotective compounds to treat acute ischemic stroke: guidelines to develop pleiotropic molecules.

Authors:  Paul A Lapchak
Journal:  Transl Stroke Res       Date:  2013-06       Impact factor: 6.829

Review 8.  Mitochondrial uncoupling as a therapeutic target following neuronal injury.

Authors:  P G Sullivan; Joe E Springer; Edward D Hall; Stephen W Scheff
Journal:  J Bioenerg Biomembr       Date:  2004-08       Impact factor: 2.945

9.  Impact of hypoglycemia and diabetes on CNS: correlation of mitochondrial oxidative stress with DNA damage.

Authors:  Puneet Singh; Anu Jain; Gurcharan Kaur
Journal:  Mol Cell Biochem       Date:  2004-05       Impact factor: 3.396

Review 10.  Ascomycin and FK506: pharmacology and therapeutic potential as anticonvulsants and neuroprotectants.

Authors:  Germán Sierra-Paredes; Germán Sierra-Marcuño
Journal:  CNS Neurosci Ther       Date:  2008       Impact factor: 5.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.